Skip to main content

ExodusPoint Capital Management, LP

Position in CSTL — Castle Biosciences Inc

CIK 1736225 NEW YORK, NY

Position in CSTL

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$800,526
-$752,285 QoQ
Shares Held
32,608
-58.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Derivatives in CSTL

reported options exposure · as of Dec 31, 2020
CallValue
$1,416,865
CallShares
21,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $77,228,781 across 7 Diagnostics & Research names. CSTL ranks #6 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 CSTL
Castle Biosciences Inc
This page
32,608 $800,526

All Filings in CSTL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $800,526 32,608
2025-03-31 $1,552,811 77,563
2024-12-31 $306,048 11,484
2024-09-30 $1,262,380 44,263
2024-06-30 $873,738 40,135
2023-06-30 $874,965 63,773
2023-03-31 $510,768 22,481
2020-12-31 $1,416,865 21,100
2020-06-30 $220,750 5,857